NEUROMODULATION DEVICES MARKET ANALYSIS

Neuromodulation Devices Market, by Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Gastric Electric Stimulation Devices), by Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism and GIT Management and Others (Incontinence Management, etc.)) by End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Others (Nursing Facilities, etc.)) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023
Code : CMI3861
Pages :170
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Neuromodulation Devices Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global neuromodulation devices market over the forecast period. North America holds 37.8% of the market share due to the increasing prevalence of neurological disorders, which is expected to drive the North America neuromodulation devices market over the forecast period. For instance, according to Alzheimer’s Association, it was stated that around 5.8 million people in the U.S. aged 65 and older were living with alzheimer’s dementia in 2020.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa